Cargando…
The expression of histone deacetylase HDAC1 correlates with the progression and prognosis of gastrointestinal malignancy
Gastrointestinal malignancy is a severe public health threat worldwide, and survival for most types of gastrointestinal cancer is very poor. Therefore, finding better cancer biomarkers to diagnose gastrointestinal malignancy and predict patient survival is essential. HDAC1 has been reported to be cl...
Autores principales: | Cao, Lin-Lin, Yue, Zhihong, Liu, Lianhua, Pei, Lin, Yin, Yue, Qin, Li, Zhao, Jie, Liu, Huixin, Wang, Hui, Jia, Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503610/ https://www.ncbi.nlm.nih.gov/pubmed/28424407 http://dx.doi.org/10.18632/oncotarget.16843 |
Ejemplares similares
-
Histone deacetylase HDAC1 expression correlates with the progression and prognosis of lung cancer: A meta-analysis
por: Cao, Lin-Lin, et al.
Publicado: (2017) -
Histone Deacetylase (HDAC) Inhibitors for the Treatment of Schistosomiasis
por: Ghazy, Ehab, et al.
Publicado: (2022) -
Class I histone deacetylases (HDAC1–3) are histone lysine delactylases
por: Moreno-Yruela, Carlos, et al.
Publicado: (2022) -
The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugs
por: Vaca, Hugo Rolando, et al.
Publicado: (2021) -
Upregulated Histone Deacetylase 6 Associates with Malignant Progression of Melanoma and Predicts the Prognosis of Patients
por: Hu, Zhicheng, et al.
Publicado: (2020)